Brief: Enteris BioPharma Presents Data From Two Clinical Studies Of Leuprolide At ENDO 2022

SWK Holdings

13/06/2022 14:19

June 13 (Reuters) - Enteris BioPharma Inc:
    * ENTERIS BIOPHARMA PRESENTS DATA FROM TWO CLINICAL STUDIES
INVOLVING ORAL FORMULATIONS OF LEUPROLIDE AT ENDO 2022 ANNUAL
CONFERENCE

Source text for Eikon:  ID:nPnbfRqc6a 
Further company coverage:  SWKH.O 

 ((Reuters.Briefs@thomsonreuters.com;))